Nektar Therapeutics (Nasdaq: NKTR) has had quite a day to say the least. The stock has dropped nearly 15 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE